Assertion list
effect (aspect of drug ) → ReceivesAction

Results from Ascent++: 257
effectReceivesAction determined 0.65
effectReceivesAction felt 0.64
effectReceivesAction achieved 0.60
effectReceivesAction understood 0.59
effectReceivesAction studied 0.59
effectReceivesAction reduced 0.58
effectReceivesAction avoided 0.56
effectReceivesAction limited 0.55
effectReceivesAction treated 0.54
effectReceivesAction decreased 0.54
effectReceivesAction reported to the fda 0.53
effectReceivesAction increased 0.53
effectReceivesAction monitored 0.53
effectReceivesAction explored 0.52
effectReceivesAction managed 0.52
effectReceivesAction seen in patient 0.52
effectReceivesAction related 0.52
effectReceivesAction provided 0.52
effectReceivesAction reviewed 0.51
effectReceivesAction eliminated 0.51
effectReceivesAction associated with chemotherapy 0.51
effectReceivesAction minimized 0.50
effectReceivesAction reversed 0.50
effectReceivesAction likely to occur 0.49
effectReceivesAction observed in study 0.49
effectReceivesAction caused by drug 0.49
effectReceivesAction seen with drug 0.48
effectReceivesAction associated with the drug 0.48
effectReceivesAction experienced by patient 0.47
effectReceivesAction produced by the drug 0.47
effectReceivesAction controlled 0.46
effectReceivesAction alleviated 0.46
effectReceivesAction caused by steroid 0.46
effectReceivesAction expected 0.45
effectReceivesAction amplified 0.45
effectReceivesAction altered 0.45
effectReceivesAction described 0.45
effectReceivesAction reported 0.44
effectReceivesAction mitigated 0.44
effectReceivesAction delayed 0.44
effectReceivesAction enhanced 0.43
effectReceivesAction manifested 0.43
effectReceivesAction reported to the doctor 0.43
effectReceivesAction difficult to predict 0.43
effectReceivesAction associated with medication 0.43
effectReceivesAction shown in table 0.43
effectReceivesAction reported by patient 0.42
effectReceivesAction lived 0.42
effectReceivesAction taken into account 0.41
effectReceivesAction attributed 0.41
effectReceivesAction observed 0.41
effectReceivesAction noted 0.41
effectReceivesAction documented 0.41
effectReceivesAction tolerated 0.40
effectReceivesAction overcome 0.40
effectReceivesAction associated with treatment 0.40
effectReceivesAction associated with long-term use 0.39
effectReceivesAction caused 0.39
effectReceivesAction under-reported 0.39
effectReceivesAction mediated 0.38
effectReceivesAction studied in mouse 0.38
effectReceivesAction associated with older drugs 0.38
effectReceivesAction reported by user 0.38
effectReceivesAction seen in child 0.38
effectReceivesAction lost 0.38
effectReceivesAction reported by participant 0.38
effectReceivesAction seen in dog 0.38
effectReceivesAction dramatic to say the 0.38
effectReceivesAction maintained 0.38
effectReceivesAction prolonged 0.38
effectReceivesAction exacerbated 0.37
effectReceivesAction improved 0.37
effectReceivesAction required 0.37
effectReceivesAction obtained 0.37
effectReceivesAction tested 0.37
effectReceivesAction associated with opioid 0.36
effectReceivesAction studied in rat 0.36
effectReceivesAction desired 0.36
effectReceivesAction balanced with potential benefits 0.36
effectReceivesAction proven 0.36
effectReceivesAction reported in trial 0.35
effectReceivesAction blocked 0.35
effectReceivesAction studied in rabbit 0.35
effectReceivesAction seen in people 0.35
effectReceivesAction associated with effexor 0.35
effectReceivesAction discovered 0.35
effectReceivesAction studied for many years 0.34
effectReceivesAction studied in 10 healthy subjects 0.34
effectReceivesAction associated with antihistamine 0.34
effectReceivesAction aimed 0.34
effectReceivesAction achieved at lower doses 0.33
effectReceivesAction caused by improper use of the m… 0.33
effectReceivesAction explained 0.33
effectReceivesAction seen in athlete 0.33
effectReceivesAction shown in figure 0.33
effectReceivesAction managed by dosage adjustments 0.33
effectReceivesAction associated with amantadine 0.32
effectReceivesAction associated with phentermine 0.32
effectReceivesAction treated with additional medicat… 0.32
effectReceivesAction based 0.32
effectReceivesAction compared to placebo 0.32
effectReceivesAction weakened 0.32
effectReceivesAction stopped 0.32
effectReceivesAction associated with other applicati… 0.31
effectReceivesAction associated with statin 0.31
effectReceivesAction addressed 0.31
effectReceivesAction blocked by the coadministration… 0.31
effectReceivesAction dependent on the route of admin… 0.31
effectReceivesAction induced 0.31
effectReceivesAction selected 0.31
effectReceivesAction exaggerated 0.31
effectReceivesAction offset by increased rate of cer… 0.30
effectReceivesAction associated with cannabi 0.30
effectReceivesAction caused by radiation 0.30
effectReceivesAction compared 0.30
effectReceivesAction demonstrated in vitro 0.30
effectReceivesAction discussed in greater detail 0.30
effectReceivesAction experienced by the user 0.30
effectReceivesAction magnified 0.30
effectReceivesAction overlooked 0.30
effectReceivesAction associated with the use of cycl… 0.29
effectReceivesAction seen in cat 0.29
effectReceivesAction produced 0.29
effectReceivesAction multiplied 0.29
effectReceivesAction prescribed for child 0.29
effectReceivesAction mixed with alcohol 0.29
effectReceivesAction assessed by coronary angiography 0.29
effectReceivesAction balanced 0.29
effectReceivesAction classified as low risk 0.29
effectReceivesAction corroborated by similar findings 0.29
effectReceivesAction discovered by accident 0.29
effectReceivesAction reached 0.29
effectReceivesAction repeated 0.29
effectReceivesAction seen in woman 0.29
effectReceivesAction shown in fig 0.29
effectReceivesAction sustained 0.29
effectReceivesAction separated 0.28
effectReceivesAction touched 0.28
effectReceivesAction underestimated 0.28
effectReceivesAction associated with progesterone 0.27
effectReceivesAction affected 0.27
effectReceivesAction associated with cardiovascular … 0.27
effectReceivesAction associated with therapy 0.27
effectReceivesAction attenuated 0.27
effectReceivesAction concentrated 0.27
effectReceivesAction due to chance 0.27
effectReceivesAction heard 0.27
effectReceivesAction isolated 0.27
effectReceivesAction kept in mind 0.27
effectReceivesAction maintained in long-term follow-… 0.27
effectReceivesAction mixed 0.27
effectReceivesAction removed 0.27
effectReceivesAction reversed with known antidote 0.27
effectReceivesAction stated 0.27
effectReceivesAction pronounced 0.26
effectReceivesAction limited to gastric upset 0.26
effectReceivesAction recorded 0.25
effectReceivesAction detected 0.25
effectReceivesAction appreciated 0.25
effectReceivesAction assessed by b-mode ultrasonogra… 0.25
effectReceivesAction associated with adverse drug in… 0.25
effectReceivesAction associated with marijuana use 0.25
effectReceivesAction associated with thc 0.25
effectReceivesAction attributed to a hyporeninemic-h… 0.25
effectReceivesAction attributed to inhibition of ren… 0.25
effectReceivesAction based on the type of cancer 0.25
effectReceivesAction beobtained by same amount of fo… 0.25
effectReceivesAction caught 0.25
effectReceivesAction caused by some cancer treatments 0.25
effectReceivesAction checked 0.25
effectReceivesAction checked before departure 0.25
effectReceivesAction combined with cannabis 0.25
effectReceivesAction confirmed in human 0.25
effectReceivesAction documented in medical journals 0.25
effectReceivesAction examined in absolute terms 0.25
effectReceivesAction extrapolated 0.25
effectReceivesAction indicated in instruction 0.25
effectReceivesAction investigated in 260 0.25
effectReceivesAction listed in the package insert 0.25
effectReceivesAction maximized 0.25
effectReceivesAction mediated by action 0.25
effectReceivesAction mediated by receptor 0.25
effectReceivesAction mimicked 0.25
effectReceivesAction muted 0.25
effectReceivesAction observed in experiment 0.25
effectReceivesAction produced by adderall 0.25
effectReceivesAction produced by delta-9-thc 0.25
effectReceivesAction produced by triamterene 0.25
effectReceivesAction referred 0.25
effectReceivesAction reflected in the ecg 0.25
effectReceivesAction replicated 0.25
effectReceivesAction reported in the one trial 0.25
effectReceivesAction reversed by rimonabant 0.25
effectReceivesAction reversed by sufficient doses of… 0.25
effectReceivesAction seen after intravenous administ… 0.25
effectReceivesAction solved 0.25
effectReceivesAction studied in eight subjects 0.25
effectReceivesAction taken along with other substanc… 0.25
effectReceivesAction targeted 0.25
effectReceivesAction uncovered 0.25
effectReceivesAction difficult to deal 0.25
effectReceivesAction thought 0.24
effectReceivesAction common in people 0.24
effectReceivesAction discovered in 1982 0.24
effectReceivesAction worsened 0.24
effectReceivesAction offset 0.23
effectReceivesAction weakened in patient 0.23
effectReceivesAction abused 0.23
effectReceivesAction associated with increasing doses 0.23
effectReceivesAction associated with each drug 0.21
effectReceivesAction associated with fluoroquinolone… 0.21
effectReceivesAction missed 0.21
effectReceivesAction associated with medicine 0.21
effectReceivesAction associated with nsaid 0.20
effectReceivesAction countered 0.20
effectReceivesAction easy to tolerate 0.20
effectReceivesAction established 0.19
effectReceivesAction observed after 6 weeks 0.19
effectReceivesAction reported in addition 0.19
effectReceivesAction aggravated 0.18
effectReceivesAction associated with lipitor 0.18
effectReceivesAction difficult to treat 0.18
effectReceivesAction dismissed 0.18
effectReceivesAction hidden 0.18
effectReceivesAction listed below don't 0.18
effectReceivesAction resolved 0.17
effectReceivesAction associated with antibiotic 0.16
effectReceivesAction associated with levaquin 0.16
effectReceivesAction associated with the use of mann… 0.16
effectReceivesAction associated with valium 0.16
effectReceivesAction blocked by another drug 0.16
effectReceivesAction blocked in dose-dependent manner 0.16
effectReceivesAction caused by typical antipsychotics 0.16
effectReceivesAction common in the elderly 0.16
effectReceivesAction compounded 0.16
effectReceivesAction described as disorganization 0.16
effectReceivesAction disclosed 0.16
effectReceivesAction downplayed 0.16
effectReceivesAction listed on the label 0.16
effectReceivesAction overcome for time 0.16
effectReceivesAction produced by the rush 0.16
effectReceivesAction questioned 0.16
effectReceivesAction recommended 0.16
effectReceivesAction seen in thisclass of animal 0.16
effectReceivesAction suppressed 0.16
effectReceivesAction seen in mouse 0.15
effectReceivesAction reported in clinical studies 0.15
effectReceivesAction discontinued 0.13
effectReceivesAction detected in small clinical trial 0.11
effectReceivesAction observed in surviving offspring 0.11
effectReceivesAction published 0.11
effectReceivesAction encountered 0.10
effectReceivesAction observed at 10 mg/kg 0.09
effectReceivesAction observed on other fertility 0.09
effectReceivesAction observed on reproductive parame… 0.09
effectReceivesAction mentioned by clinician 0.03
effectReceivesAction mentioned by news media 0.03